Arkolith/Insider Trading/LRMR/Form 4

Hamilton Thomas Edward

DirectorLarimar Therapeutics, Inc. (LRMR) · full profile →Form 4 · filed Jul 2, 2021
Net Buying
Open-Market Buys
$496K
Open-Market Sells
$0
Net Open-Market Flow
$496K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)57K$8.75$496K190K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001192482-21-000601) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML